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Abstract
Objective: To describe the prevalence of dementia and subtypes in a general elderly population in northwestern
Spain and to analyze the influence of socio-demographic factors.
Methods: Cross-sectional, two-phase, door-to-door, population-based study. A total of 870 individuals from a rural
region and 2,119 individuals from an urban region of Valladolid, Spain, were involved. The seven-minute screen
neurocognitive battery was used in the screening phase. A control group was included.
Results: A total of 2,170 individuals aged 65 to 104 years (57% women) were assessed. There were 184 subjects
diagnosed with dementia. The crude prevalence was 8.5% (95% CI: 7.3-9.7). Age- and sex-adjusted prevalence was
5.5 (95% CI: 4.5-6.5). Main subtypes of dementia were: Alzheimer’s disease (AD) 77.7%, Lewy Body disease, 7.6%
and vascular dementia (VD) 5.9%. Crude prevalences were 6.6% (AD), 0.6% (Lewy Body disease), and 0.5% (VD).
Dementia was associated with age (OR 1.14 for 1-year increase in age), female sex (OR 1.79) and the absence of
formal education (OR 2.53 compared to subjects with primary education or more).
Conclusion: The prevalence of dementia in the study population was lower than the most recent estimates for
Western Europe. There was a high proportion of AD among all dementia cases and very low prevalence of VD. Old
age, female sex, and low education level were independent risk factors for dementia and AD.
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Introduction
In 2012, the European Commission published predicted
population changes in European Union countries for the
following 50 years [1]. It was projected that the percentage of
people aged 65 years or more will increase from 17% to 30%,
and the percentage of people over 80 will increase from 5% to
12%. This effect is likely to be particularly relevant to Spain,
where female life expectancy already reaches 85 years, which
is the highest in Europe [2]. In this context, neurological
diseases, especially dementia, pose a challenge for healthcare
systems worldwide [3]. For 2010, the overall cost of dementia
was estimated at 210 billion USD in Western Europe alone [4].
The most recent systematic review of worldwide dementia
prevalence and future projections was published in 2013 [5].
The 2010 estimate for Western Europe (7.3% prevalence in
individuals aged 60 years or more) represents a considerable
increase compared to the 2005 Delphi consensus [6]. These
projections assume that disease prevalence will remain stable
over time, which can greatly limit their validity [7]. These
estimates can be substantially altered by a better control of
vascular risk factors [8] or by the emergence of treatments that
can alter the course of the disease, slow its progress, or
increase survival rates. Moreover, study methods themselves
can potentially introduce important sources of variability in the
prevalence rates [9]. Therefore, it is necessary to monitor the
epidemiology of dementia in different parts of the world. In that
respect, the decrease in the number of studies on dementia
prevalence in developed countries since 1990 is alarming [5].
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Several population-based studies on dementia have been
conducted in Spain over the last two decades. These studies
have shown varying prevalence rates, which are largely due to
methodological differences [10,11]. For the most part, research
has focused on the prevalence of Alzheimer’s disease (AD)
and vascular dementia (VD). The prevalences of other primary
dementias, such as dementia with Lewy bodies (DLB) or
frontotemporal dementia (FTD), have barely been addressed
[12,13]. In 2009, Virués et al. estimated the age- and sex-
adjusted dementia prevalence to be 7.5% in Spain among
individuals aged ≥ 75 years. They analyzed nine Spanish
population samples, which were obtained from the population
of survivors who participated in prior population-based studies
[14].
The DEMINVALL project is an epidemiological study of
dementia conducted in the province of Valladolid, northwestern
Spain. Its main objectives are to 1) describe the prevalence of
dementia and its subtypes; 2) identify the frequency,
characteristics, and determining factors of undiagnosed
dementia in the community; and 3) assess the effects of
nutritional status and diet characteristics on dementia. In this
report, we present the results of the prevalence study and
analyze the effects of age, gender, education level, and place
of residence (rural or urban setting) on dementia prevalence.
Materials and Methods
DEMINVALL is a cross-sectional, two-phase, door-to-door,
population-based study. The prevalence date was February 1,
2009. To be eligible, individuals must have been aged ≥ 65
years on the prevalence date and must have lived at least 6
months of the previous year in the selected geographic area. A
detailed description of the study methods, main demographic
and sociocultural findings, and analysis of the participant
attrition can be found elsewhere [15].
Study population
A mixed urban and rural population was selected.
Community-dwelling and nursing home residents were
included. The rural population was composed of subjects aged
≥ 65 years of 11 townships west of the Valladolid province (870
residents). This region is characterized by low population
density and lower socioeconomic status among individuals
belonging to this age category. The urban population was
selected from subjects aged ≥ 65 years of the Parquesol and
Campo Grande health districts in the city of Valladolid (6,183
residents). Due to the large population size, the survey was
based on a 34.2%, random, 5-year, age- and sex-stratified
sample comprising 2,119 individuals. The size was calculated
in order to provide an estimated 6.5% prevalence, 1%
precision, 95% confidence interval (CI), and 20% expected
losses. Participants were selected from the registry of Social
Security health card holders, which provides virtually universal
coverage for the population in this province. The data were
provided by the local healthcare authorities and had been
updated most recently on November 1, 2008. On this date, the
immigration rate in this portion of the population was below 1%
for the province.
Phase 1: Screening
The screening phase was conducted between February
2009 and February 2010. The study was extensively advertised
to increase participation, and an information letter was sent to
all of the selected participants. Screening was conducted by 27
primary care doctors and 1 geriatrician, all of whom were
trained specifically for the study protocol. Screening interviews
were conducted at healthcare centers, rural doctors’ offices, or
at participants’ homes. A structured questionnaire was
administered to collect information regarding medical,
educational, sociodemographic, employment, and lifestyle
histories. The detection of dementia in primary care and the
existence of prior consultations for cognitive impairment,
complaint symptoms and level of care in which they were held
were analyzed. All patients with a prior diagnosis of dementia
were evaluated during the second phase of the study.
The Spanish version of the 7-Minute Screen Neurocognitive
Battery (7MS) was used as a screening tool [16]. A total score
below 20 (8th percentile) was considered positive. This scoring
system was chosen due to its higher discriminatory power in
the validation of the Spanish version of the test [17,18] and
because it is the cutoff point that is customarily used in clinical
practice in Spain. Whenever administration of the 7MS was not
possible, the abbreviated Spanish version of the Informant
Questionnaire on Cognitive Decline in the Elderly (IQCODE)
[19] was employed. A score of 57 or higher was considered
positive. In cases of death after the prevalence date,
collaboration of a close relative was requested, and a Spanish
version of the Kawas Dementia Questionnaire [20] was
administered. This instrument provides a structural review of
the general diagnostic criteria of dementia and subtypes.
Phase 2: Diagnostic confirmation
The second phase was conducted by four neurologists, one
geriatrician, and three neuropsychologists between May 2009
and May 2010. Participants were evaluated via external
consultation with the neurology, geriatric, and clinical
psychology departments of the Río Hortega University
Hospital. When necessary, participants were evaluated at their
homes. Comprehensive neurological and neuropsychological
assessments were offered to all individuals who screened
positive. In addition, a randomly selected control group of 160
subjects was included (8.3% of those who screened negative).
The proportions of sex and age stratification with regard to
those who screened positive were respected. A systematic
laboratory study (including ApoE genotyping) and brain
imaging tests (cranial CT or 1.5T MRI) were performed. For
cases of parkinsonism-related dementia, a single-photon
emission computed tomography imaging study with123 FP-CIT
(DaTSCAN; GE Healthcare) was performed.
The neuropsychological evaluation consisted of the Spanish
version of the Cambridge Examination of Mental Disorders of
the Elderly [21]. This instrument includes a cognitive
assessment (Cambridge Cognitive Examination), functional
and neuropsychiatric assessments, and an informant interview.
Disabilities were evaluated using the Rapid Disability Rating
Scale-2 [22], and the severity of dementia was assessed using
the Clinical Dementia Rating (CDR) [23].
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Clinical diagnosis of dementia and subtype was established
by consensus between the researchers involved in phase 2.
The post-mortem dementia questionnaires were evaluated by
the principal investigator. The DSM-IV criteria [24] were applied
for the diagnosis of dementia syndrome. Additionally, the
NINCDS-ADRDA criteria for AD [25], the NINDS-AIREN criteria
for VD [26], and the Neary criteria for FTD [27] were used to
classify dementia subtypes. Cases of dementia associated with
parkinsonism were grouped under the denomination of Lewy
body disease (LBdis), including DLB, according to McKeith’s
criteria [28], and Parkinson’s disease-associated dementia
(PDD). Presentation of parkinsonism at least one year prior to
dementia was the temporal criteria used to diagnose PDD. AD
with cerebrovascular disease was regarded as present in those
patients that met the criteria of NINCDS-ADRDA for possible
AD and who presented significant levels of small vessel
ischemic changes, strategic lacunar or large vessel infarcts on
brain imaging and, in addition, who had a history of stroke or
impaired neurological examination (focal deficit or gait
disturbances). Secondary dementia was classified as having
an identifiable cause. When the clinical information was
insufficient to reach an etiologic classification, undetermined
dementia was diagnosed.
Ethics Statement
This study was approved by the Ethics and Clinical
Investigation Committee of the Rio Hortega University Hospital
of Valladolid (Comité Ético de Investigación Clínica del Hospital
Universitario Río Hortega de Valladolid) and the Regional
Health Management Office of Castilla y León (SACYL). All
participants provided written informed consent prior to
participation. Their capacity to consent was judged by
experienced physicians before starting the interview, thus
clinician-based. In cases where capacity to consent was
doubted, informed consent was obtained by next of kin, care
takers as well as guardians on the behalf of participants.
Clinical follow-up was offered to all patients with undetected
dementia. All other non-neurological processes detected were
reported to the primary care physicians. Appropriate measures
were taken to ensure confidentiality of the data. The database
was inscribed in the Spanish Agency for Data Protection.
Statistical analyses
Point prevalence was used to measure disease frequency.
Non-responders (non-located and refusals) were excluded from
the prevalence calculation. Age- and sex-specific prevalence
were calculated in 5-year intervals, from ≥ 65 to ≥ 90 years,
with a 95% CI based on a binomial distribution. Age-adjusted
and age- and sex-adjusted prevalence of dementia was
obtained. European standard population weights were used
with the following weightings: 0.36, 0.27, 0.18, 0.09, and 0.09
for ages 65-69, 70-74, 75-79, 80-84, and ≥85, respectively, and
0.5 for both males and females. Pearson’s chi-squared test
was used to evaluate differences between categorical
variables. A multivariate analysis with logistic regression was
used to assess the association between risk factors, dementia,
and AD. Age was introduced as a continuous variable.
Adjusted odds ratios (OR) were calculated with 95% CI. In all
cases, the significance level was set at < 0.05. SPSS software
version 15.0 (SPSS, Inc., Chicago, IL) was used for all
statistical analyses.
Results
Population attrition and the results of the clinical work-up are
depicted in Figure 1. Out of the 2,989 individuals initially
selected, 227 (7.6%) were excluded for not satisfying the
inclusion criteria. The participation rate among eligible subjects
was 79%. A total of 2,170 individuals aged between 65 and
104 years (mean age: 76.5 ± 7.8 years; 57% females; 5.2%
institutionalized) were screened. Among these, 1,459 subjects
were from the urban area and 711 from the rural area.
Table 1 presents the education levels of the participants who
provided this information (n=2,118). The percentage of illiterate
or subjects without formal education was significantly higher in
women than in men (24.6% vs. 19.8%, p<0.01), as well as in
rural areas than in urban areas (42.1% vs. 13%, p<0.001).
A total of 241 (11%) subjects had positive screenings. Of
these, 212 (88%) were assessed during the second phase, in
which 184 dementia cases were identified (mean age: 84.1 ±
7.1 years; 75% females; 32.1% institutionalized). There was a
previous diagnosis of dementia in 83 subjects (45.1%) and a
family history of dementia in at least one first-degree relative in
28 subjects (15.2% of the total of identified cases). Two false-
negatives (one AD and one VD) were found in the control
group. Dementia subtypes and their frequencies were as
follows: AD 143 (77.7%), LBdis 14 (7.6%), VD 11 (6%), FTD 1
(0.5%), secondary dementias 8 (4.3%), and undetermined
dementia 7 (3.8%). In the AD group, 19 patients had
associated cerebrovascular disease. Of the 14 individuals in
the LBdis group, 10 were classified as DLB and 4 as PDD. In
the secondary dementia group, the following were identified:
three cases of disseminated neoplasia with brain involvement,
two cases of normal pressure hydrocephalus, two related to
alcohol abuse, and one of anoxic encephalopathy due to
cardiac arrest.
According to the CDR, 30.4% had mild dementia, 29.9%
moderate dementia, and 39.7% advanced dementia.
Neuroimaging tests were conducted in 125 (68%) of the 184
dementia patients. APOE genotyping was conducted in 123
cases; 38% were APOE ε4-positive. This percentage was
42.7% for AD (APOE ε4-positive in 41 of 96 AD patients who
underwent this test). Among the 83 patients with previously
diagnosed dementia, 21 (25.3%) were under treatment with
acetylcholinestarase inhibitors, 12 with memantine (14.5%) and
3 (3.6%) in combined therapy. As a whole, 36 patients out of
the total of 184 (19.6%) identified in the study were receiving
disease modifying drugs.
Table 2 shows the crude, age-adjusted and age- and sex-
adjusted prevalence of dementia. The crude prevalence of
overall dementia was 8.5% (95% CI: 7.3-9.7). The prevalence
was greater in women than in men (11.2% vs. 4.9%, p<0.001)
and in subjects with low education levels. There were no
significant differences between prevalence values obtained
from the rural and urban areas. The age- and sex-adjusted
prevalence of dementia for subjects ≥ 75 years of age was
Prevalence of Dementia in Valladolid, Spain
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Figure 1.  Study flow chart with results from the screening and diagnostic phases.  AD: Alzheimer’s disease.
LBdis: Lewy body disease.
DLB: Dementia with Lewy bodies.
PDD: Parkinson´s disease-associated dementia.
VD: Vascular dementia.
FTD: Fronto-temporal dementia .
SD: Secondary dementia.
UD: Undetermined dementia.
doi: 10.1371/journal.pone.0077688.g001
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12.4% (95% CI: 10.5-14.3). The crude prevalence of dementia
in 113 institutionalized subjects was 52.2% (95% CI: 43-61.4).
Table 3 shows the age- and sex-specific prevalences of the
main dementia subtypes. The frequency of dementia and AD
was below 2% of individuals of each gender aged 65 to 75
years. The frequency of dementia and AD clearly increased in
individuals aged ≥ 75 years, except in males aged ≥ 85 years.
Table 4 details the influence of various sociodemographic
variables on dementia and AD. The adjusted OR of the logistic
regression analysis are presented. A strong association was
found between age, female gender, and low education level for
both dementia and AD.
Discussion
The DEMINVALL study offers good global quality parameters
according to quality criteria proposed to assess studies of
dementia prevalence based on the sample size, study design,
inclusion of a control group, degree of participation, and
diagnostic procedures [5]. After adjusting for age and sex, the
prevalence of dementia and AD in our population fell into an
intermediate-low range compared to previously published rates
in other Spanish [10] and Western European populations
[5,29,30]. We found a considerable preponderance of AD, very
low frequency of VD, and low prevalence of dementia in
subjects aged ≤ 75 years. The age- and sex-adjusted dementia
prevalence was clearly higher (12.4% vs. 7.5% in subjects
aged ≥ 75 years) compared to a recent multicenter Spanish
study [14]. Therefore, the large number of dementia patients in
our region seems to be highly influenced by population aging
and the particularly increased life expectancy of women. Table
5 shows the crude prevalences of dementia, AD and VD of
some population-based surveys in southern Europe within the
last few years. The most recent that include the prevalence of
dementia and its subtypes have been selected [11,12,31-34].
Table 1. Participant education levels organized by living
environment and gender.
 
Urban population
(n=1,425)
Rural population
(n=693)
Total population
(n=2,118)
Education
level Men, n (%)
Women, n
(%) Men, n (%)
Women, n
(%) Men, n (%)
Women,
n (%)
Illiterate 1 (0,2%) 7 (0,8%) 4 (1,2%) 13(3,7%) 5 (0,5%) 20 (1,7%)
Less than
primary
school
50
(8,7%)
127
(14,9%)
126
(36,8%)
148
(42,2%)
176
(19,2%)
275
(22,9%)
Primary
school
247
(43,1%)
472
(55,4%)
196
(57,3%)
178
(50,7%)
443
(48,4%)
650
(54,0%)
Secondary
school and
higher
275
(48,0%)
246
(28,9%)
16
(4,7%)
12
(3,4%)
291
(31,8%)
258
(21,4%)
Total 573(100%)
852
(100%)
342
(100%)
351
(100%)
915
(100%)
1,203
(100%)
doi: 10.1371/journal.pone.0077688.t001
Table 2. Crude, age-adjusted and age- and sex-adjusted
prevalence of dementia and subtypes, organized by living
environment and education level.
 Crude prevalence
Age-adjusted
prevalence
Age- and sex-
adjusted
prevalence
 PR PE (95% CI) PE (95% CI) PE (95% CI)
Prevalence by
dementia
subtype
 
Overall dementia  
Men 46/933 4.9 (3.5-6.3) 4.0 (2.7-5.3)  
Women 138/1237 11.2 (9.4-12.9) 7.0 (5.6-8.4)  
Both 184/2170 8.5 (7.3-9.7) 6.0 (5.0-7.0) 5.5 (4.5-6.5)
Alzheimer´s
disease  
Men 26/933 2.8 (1.7-3.8) 2.2 (1.3-3.1)  
Women 117/1237 9.5 (7.8-11.1) 5.8 (4.5-7.1)  
Both 143/2170 6.6 (5.5-7.6) 4.5 (3.6-5.4) 4.0 (3.2-4.8)
Vascular
dementia  
Men 4/933 0.4 (0-0.8) 0.3 (0-0.7)  
Women 7/1237 0.6 (0.1-1.0) 0.3 (0-0.6)  
Both 11/2170 0.5 (0.2-0.8) 0.4 (0.1-0.7) 0.3 (0.1-0.5)
Lewy body
disease  
Men 6/933 0.6 (0.1-1.2) 0.4 (0-0.8)  
Women 8/1237 0.6 (0.2-1.1) 0.5 (0.1-0.9)  
Both 14/2170 0.6 (0.3-1.0) 0.5 (0.2-0.8) 0.5 (0.2-0.8)
Prevalence by
residential
environment
 
Urban residential
environment  
Men 33/585 5.6 (3.8-7.5) 4.5 (2.8-6.2)  
Women 91/874 10.4 (8.4-12.4) 6.3 (4.7-7.9)  
Both 124/1459 8.5 (7.1-9.9) 5.8 (4.6-7.0) 5.4 (4.2-6.6)
Rural residential
environment  
Men 13/348 3.7 (1.7-5.7) 3.1 (1.3-4.9)  
Women 47/363 12.9 (9.5-16.4) 8.8 (5.9-11.7)  
Both 60/711 8.4 (6.4-10.5) 6.3 (4.5-8.1) 5.9 (4.2-7.6)
Prevalence by
education level  
Illiterate 8/25 32.0(13.7-50.3)
23.1
(6.6-39.7)
28.7
(11.0-46.5)
Less than primary
school 51/451 11.3 (8.4-14.2) 7.8 (5.3-10.2) 7.3 (4.9-9.7)
Primary school 86/1093 7.9 (6.3-9.5) 5.3 (4.0-6.6) 4.9 (3.6-6.1)
Secondary school
and higher 20/549 3.6 (2.1-5.2) 3.1 (1.7-4.6) 2.8 (1.1-4.1)
PR: Crude prevalence ratio (cases divided by population). PE: Point prevalence
estimation. CI: Confidence interval.
doi: 10.1371/journal.pone.0077688.t002
Prevalence of Dementia in Valladolid, Spain
PLOS ONE | www.plosone.org 5 October 2013 | Volume 8 | Issue 10 | e77688
The age- and sex-adjusted prevalence rates were higher in
the rural population than in the urban population, but this
difference was not significant. Both the higher proportion of
women in the urban area (60% vs. 52%) and the lower
educational level in the rural area could have contributed to
balancing out possible prevalence differences that have been
previously reported in other studies, with higher prevalence
rates in rural areas, especially in AD [35].
We analyzed the frequency of dementia associated with
parkinsonism as a group termed LBdis, using a temporary
criterion to differentiate between DLB and PDD. Although the
literature on this disease is limited, our results support those
reported in other studies [36,37]. We found a crude prevalence
of 0.6%, which represented 7.6% of all dementia cases and
was the second-most prevalent subtype after AD. In Spain,
studies conducted in El Prat de LLobregat and Munguialde
have reported similar numbers for LBdis prevalence, although
lower than VD [12,13].
The most striking finding of the DEMINVALL study is the low
prevalence of VD, which is the lowest ever described in Spain
[10,14] and one of the lowest described in Europe [38]. Some
aspects of the study methods may have contributed to this
result. First, the screening method, 7MS, was originally
designed as an AD detection test, although it has proven useful
for detecting other types of dementia [39]. The 7MS is a highly
sensitive and specific screening battery that primarily focuses
on episodic memory deficiencies; this may have contributed to
the high degree of AD detection but could be less sensitive to
detect VD. Nonetheless, this screening battery includes tests to
assess frontal executive functions that psychometrically exhibit
good sensitivity for detecting subcortical vascular dementia
[16]. Nevertheless, the number of false-negatives in the control
group was small. However, one case of VD was included in the
control group; this raises the possibility that other, undetected
cases existed. Second, many subjects with dementia (32%)
were not able to undergo neuroimaging tests to confirm the
presence of vascular lesions of little clinical relevance. This fact
is a major limitation of most population-based studies. Finally,
Table 4. Relation between sociodemographic factors,
dementia, and Alzheimer’s disease.
Characteristics Dementia, OR (IC 95%)
Alzheimer´s disease, OR (IC
95%)
Age, years* 1.14 (1.12-1.17) 1.15 (1.12-1.18)
Gender, women 1.79 (1.22-2.63) 2.57 (1.60-4.11)
Education   
Illiterate 9.69 (3.45-27.24) 6.58 (1.99-21.72)
Less than primary school 2.53 (1.45-4.44) 2.65 (1.38-5.11)
Primary school 1.94 (1.15-3.27) 2.21 (1.20-4.08)
Residence in rural area 0.99 (0.72-1.37) 1.14 (0.80-1.63)
Adjusted odds ratio (OR) for all variables included in the table; CI, confidence
interval.
Education level reference category: secondary education and higher.
*. Age as a continuous variable. OR for one-year age increments
doi: 10.1371/journal.pone.0077688.t004
Table 3. Age- and sex-specific counts, showing crude prevalence of dementia and its main subtypes.
Age group Population Dementia AD LBdis VD
   Cases P,% (95% IC) Cases P,% (95% IC) Cases P,% (95% IC) Cases P,% (95% IC)
Men          
65-69 253 3 1.2 (0-2.5) 1 0.4 (0-1.2) 0 --- 1 0.4 (0-1.2)
70-74 238 4 1.7 (0-3.3) 2 0.8 (0-2.0) 0 --- 0 ---
75-79 203 12 5.9 (2.7-9.2) 6 3.0 (0.6-5.3) 1 0.5 (0-1.5) 0 ---
80-84 144 18 12.5 (7.1-17.9) 10 6.9 (2.8-11.1) 4 2.8 (0.1-5.5) 3 2.1 (0-4.4)
85-89 68 5 7.4 (1.1-13.6) 4 5.9 (0.3-11.5) 1 1.5 (0-4.3) 0 ---
≥ 90 27 4 14.8 (1.4-28.2) 3 11.1 (0-23.0) 0 --- 0 ---
Women          
65-69 296 5 1.7 (0.2-3.2) 3 1.0 (0-2.2) 2 0.7 (0-1.6) 0 ---
70-74 237 4 1.7 (0-3.3) 4 1.7 (0-3.3) 0 --- 0 ---
75-79 246 25 10.2 (6.4-13.9) 21 8.5 (5.0-12.0) 1 0.4 (0-1.2) 2 0.8 (0-1.9)
80-84 220 31 14.1 (9.5-18.7) 26 11.8 (7.6-16.1) 1 0.5 (0-1.3) 2 0.9 (0-2.2)
85-89 151 41 27.2 (20.1-34.2) 33 21.9 (15.3-28.4) 4 2.6 (0.1-5.2) 1 0.7 (0-2.0)
≥ 90 87 32 36.8 (26.6-46.9) 30 34.5 (24.5-44.5) 0 --- 2 2.3 (0-5.4)
Men and women          
65-69 549 8 1.5 (0.5-2.5) 4 0.7 (0-1.4) 2 0.4 (0-0.9) 1 0.2 (0-0.5)
70-74 475 8 1.7 (0.5-2.8) 6 1.3 (0.3-2.3) 0 --- 0 ---
75-79 449 37 8.2 (5.7-10.8) 27 6.0 (3.8-8.2) 2 0.4 (0-1.1) 2 0.4 (0-1.1)
80-84 364 49 13.5 (10.0-17.0) 36 9.9 (6.8-13.0) 5 1.4 (0.2-2.6) 5 1.4 (0.2-2.6)
85-89 219 46 21.0 (15.6-26.4) 37 16.9 (11.9-21.9) 5 2.3 (0.3-4.3) 1 0.5 (0-1.3)
≥ 90 114 36 31.6 (23.0-40.1) 33 28.9 (20.6-37.3) 0 --- 2 1.8 (0-4.2)
AD: Alzheimer’s disease. LBdis: Lewy body disease. VD: Vascular dementia. P: Prevalence.
doi: 10.1371/journal.pone.0077688.t003
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the diagnostic criteria for the different subtypes of dementia,
especially VD, impose artificial constraints that
neuropathological studies have proven to be nonexistent [40]
and for which no broad consensus currently exists. In our case,
we used a restrictive criterion to diagnose AD with associated
cerebrovascular disease, which required the simultaneous
presence of clinical and neuroimaging findings. Consequently,
fewer than 15% of the AD cases met the criteria for mixed
dementia. Several patients could have also been included in
the possible VD category if clinical criteria had been strictly
enforced, as reported in the study conducted in El Prat de
Llobregat, Spain [12]. Even after considering these factors,
which may limit the validity of the obtained results, we believe
that the low prevalence of “pure” VD is a real result. The
frequency of vascular risk factors in our population [15] is
similar to Southern European countries; reduced vascular
mortality has been confirmed in these regions [41].
Furthermore, it is possible that the Mediterranean diet, which is
unique to our region, has a great impact on cardiovascular
health, especially with respect to the decrease in the incidence
of stroke and, consequently, VD [42,43].
Old age, low education level, and female sex were strongly
associated with both dementia and AD. These factors have
been previously identified, to some extent, as dementia risk
factors in developed countries [30,44]. In Spain, some authors
have found no correlation between dementia and sex [11] or
years of education [45]. The effect of age on male subjects in
our study was much less striking, similar to previous reports in
Table 5. Crude prevalence rates of dementia, Alzheimer´s
disease and vascular dementia in Southern Europe and in
the present study.
Survey area
No.
individuals
Age
(year)
Year of
survey
Dementia, P
(%)
AD, P
(%)
VD, P
(%)
Buttapietra, Italy 222 ≥ 75 1996 15.8 6.7 3.6
Conselice, Italy 1016 ≥ 65 1999 5.9 3.0 2.7
Tuscany, Italy 1600 ≥ 65 2000 6.2 4.2 1.4
El Prat de
Llobregat, Spain 1754 ≥ 70 2002 9.4 6.5 1.2
Murcia, Spain 1074 ≥ 65 2003 5.5 4.5 0.8
Sicily, Italy 280 ≥ 60 2005 7.1 4.1 1.1
Valladolid, Spain 2170 ≥ 65 2009 8.5 6.6 0.5
AD: Alzheimer’s disease. VD: Vascular dementia. P: Prevalence.
doi: 10.1371/journal.pone.0077688.t005
our country [10]. This could be related with a lower dementia
incidence [46] and a lower disease survival in men [47].
The main limitation of the present study, as with most
epidemiological population-based studies, is participation bias.
Of 2,989 individuals who were initially identified, 2,170 were
finally evaluated (79% of all eligible ones). The characteristics
of non-responders were similar to those of the evaluated group,
although greater compliance was observed in the rural area
[15]. A 20% loss to follow-up was estimated in the calculation
of the urban sample to reduce this bias. Furthermore, even
though these results could be useful for estimating dementia
cases in our geographic region, they are hard to extrapolate to
the entire Spanish population given its cultural, demographic,
and social diversity.
In conclusion, we present dementia prevalence rates in a
population from northwestern Spain. These numbers are lower
than those that have been reported for neighboring countries.
In particular, the very low prevalence of VD and the high
proportion of AD among all dementia cases are striking. The
results from future epidemiological studies in Spain and in
Western Europe will allow for the determination of whether our
findings are sporadic or if these trends in dementia truly exist,
especially for VD.
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